5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.09▲ | 1.07▲ | 1.08▲ | 1.11▼ | 0.98▲ |
MA10 | 1.08▲ | 1.08▲ | 1.08▲ | 1.04▲ | 0.97▲ |
MA20 | 1.08▲ | 1.08▲ | 1.11▼ | 0.97▲ | 1.10▼ |
MA50 | 1.10▼ | 1.10▲ | 1.05▲ | 0.96▲ | 1.37▼ |
MA100 | 1.10▼ | 1.01▲ | 0.97▲ | 1.14▼ | 2.19▼ |
MA200 | 1.02▲ | 0.95▲ | 0.96▲ | 1.34▼ | 8.14▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | 0.000▼ | -0.008▼ | 0.022▲ | 0.020▲ |
RSI | 54.383▲ | 52.248▲ | 53.496▲ | 59.835▲ | 44.230▼ |
STOCH | 90.476▲ | 47.619 | 60.644 | 72.820 | 37.744 |
WILL %R | 0.000▲ | 0.000▲ | -39.130 | -41.333 | -46.939 |
CCI | 78.515 | 99.900 | 48.462 | 49.374 | 41.190 |
Friday, May 09, 2025 05:13 AM
Inc. (“PMV Pharma” or the “Company”; Nasdaq: PMVP), a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 ...
|
Saturday, March 22, 2025 05:00 PM
Connor Clark & Lunn Investment Management Ltd. reduced its stake in shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP – Free Report) by 15.9% in the fourth quarter, according to the company in ...
|
Wednesday, March 05, 2025 06:55 AM
Shares of PMV Pharmaceuticals, Inc. (PMVP) have been struggling lately and have lost 9.8% over the past week. However, a hammer chart pattern was formed in its last trading session, which could ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 1.09 | 1.10 | 1.01 | 1.07 | 335,983 |
13/06/25 | 1.06 | 1.10 | 1.06 | 1.08 | 176,835 |
12/06/25 | 1.15 | 1.15 | 1.05 | 1.09 | 259,059 |
11/06/25 | 1.22 | 1.225 | 1.125 | 1.13 | 484,930 |
10/06/25 | 1.105 | 1.19 | 1.10 | 1.19 | 672,557 |
09/06/25 | 1.00 | 1.08 | 0.97 | 1.06 | 310,691 |
06/06/25 | 0.9392 | 0.9914 | 0.9392 | 0.97 | 799,812 |
05/06/25 | 0.94 | 0.9555 | 0.91 | 0.95 | 222,701 |
04/06/25 | 0.905 | 0.9341 | 0.905 | 0.93 | 195,437 |
03/06/25 | 0.90 | 0.9298 | 0.90 | 0.9193 | 329,850 |
|
|
||||
|
|
||||
|
|